Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine

MSF urges Gavi to reserve its special funds for pneumonia vaccine for a new manufacturer offering a more affordable version, not Pfizer and GlaxoSmithKline.

Go to Source
Date: August 26, 2019 at 09:03
Author: https://www.msf.org – catherine.wilson

0

About Admin

    You May Also Like

    error: Content is protected !!